跳至主要内容
临床试验/IRCT20130911014630N11
IRCT20130911014630N11尚未招募3 期

Evaluation of the Effects of Traditional Dosage form Called Hamol-e-Aftimone in Improving Pelvic Pain, Quality Of Life And Ovarian Cyst Size in Endometriosis Patients; A Double-Blind, Placebo-Controlled Clinical Trial

Mazandaran University of Medical Sciences0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 45 years(—)
性别
Female

入选标准

  • Age between 20 to 45
  • Endometriosis patients with pelvic pain and ovarian cyst over two centimeters
  • Absence of Müllerian anomaly, fibrosis, adenomyosis and myoma
  • No medication except NSAIDs for endometriosis within 6 months before referral
  • Presence of patient's consent to participate in the study

排除标准

  • pregnancy and lactation
  • Sever and treatment resistant pain which candidates patient for surgary
  • Absence of any acute and serious liver or kidney disease
  • Absence of pap smear with intraepithelial pathological changes
  • No history of any former or being treated malignancy

研究者

相似试验